The unlimited potential of AI & RNA
We started ShapeTX with the vision of repairing the genetic causes of disease.
We’re realizing that vision by combining AI and RNA technology to make programmable RNA medicine available for everyone.
Board of Directors

Ed Mathers
General Partner, New Enterprise Associates

Min Cui, PhD
Founder & Managing Partner, Decheng Capital

Gayathri Rajan
Chief Product Officer, DriveWealth; Former VP/GM, Google

Kelly Sims
Board Advisor, Watershed and OpenAI; Former Head of Communications, Stripe

Josef von Rickenbach, PhD
Founder & Former CEO, Parexel
Leadership

Francois Vigneault, PhD
Co-Founder
Chief Executive Officer

John Suliman
Co-Founder
Chief Financial Officer

Prashant Mali, PhD
Co-Founder
Professor, Department of Bioengineering, University of California San Diego

David Huss, PhD
Chief Scientific Officer

Lisa Taylor Ash, JD
General Counsel

Gary Fortin, PhD
Chief Operating Officer

Patrick Bigot
Chief Business Officer

Adrian Briggs, PhD
Chief Technology Officer

Ron Hause, PhD
SVP, Head of AI

Jamie Siemering
VP, People Operations

Drew Dietz, MD
VP, Clinical Research & Development

Ken Prentice
VP, Process & Product Development
Scientific Advisory Board

George Church, PhD
Professor, Genetics, Harvard Medical School

Don Cleveland, PhD
Professor, Cellular Molecular Medicine, UCSD

James Collins, PhD
Professor, Bioengineering, MIT

You. And a universe of possibilities.
If you are ready to think completely differently about science, join us.